Asparium L-Asparaginase Injection 5000 IU is a prescription oncology medicine identified as containing L-Asparaginase 5000 International Units (IU).

L-Asparaginase is an enzyme-based antineoplastic medicine used in selected combination chemotherapy regimens for acute lymphoblastic leukemia (ALL).

It works by breaking down asparagine, an amino acid required for protein synthesis.

Certain leukemia cells have a limited ability to produce sufficient asparagine and may therefore be particularly susceptible to asparagine depletion.

L-Asparaginase is an established component of selected ALL treatment protocols.

The stated 5000 IU vial strength does not establish the individual patient dose, administration route, enzyme source or formulation.

Different asparaginase products, including native E. coli-derived asparaginase, pegylated asparaginase and Erwinia-derived asparaginase, have different dosing, administration and substitution requirements.

These formulations are not automatically interchangeable.

The exact manufacturer, enzyme source, formulation, packaging, storage conditions and approved indications of Asparium must be verified from its approved Indian product documentation.

Marketed by Essentials Emporium Enterprises, Asparium is listed within the oncology pharmaceutical category for hospitals, cancer treatment centres and authorized pharmaceutical buyers.

Key Product Features